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Loss of Corneodesmosin Leads to Severe
Skin Barrier Defect, Pruritus, and Atopy:
Unraveling the Peeling Skin Disease
Vinzenz Oji,1,8 Katja-Martina Eckl,2,3,8 Karin Aufenvenne,1 Marc Na¨tebus,2 Tatjana Tarinski,1
Katharina Ackermann,4 Natalia Seller,1 Dieter Metze,1 Gudrun Nu¨rnberg,2 Regina Fo¨lster-Holst,5
Monika Scha¨fer-Korting,4 Ingrid Hausser,6 Heiko Traupe,1 and Hans Christian Hennies2,7,*
Generalized peeling skin disease is an autosomal-recessive ichthyosiform erythroderma characterized by lifelong patchy peeling of the
skin. After genome-wide linkage analysis, we have identified a homozygous nonsense mutation in CDSN in a large consanguineous
family with generalized peeling skin, pruritus, and food allergies, which leads to a complete loss of corneodesmosin. In contrast to
hypotrichosis simplex, which can be associated with specific dominant CDSN mutations, peeling skin disease is characterized by
a complete loss of CDSN expression. The skin phenotype is consistent with a recent murine Cdsn knockout model. Using three-dimen-
sional human skin models, we demonstrate that lack of corneodesmosin causes an epidermal barrier defect supposed to account for the
predisposition to atopic diseases, and we confirm the role of corneodesmosin as a decisive epidermal adhesion molecule. Therefore,
peeling skin disease will represent a new model disorder for atopic diseases, similarly to Netherton syndrome and ichthyosis vulgaris
in the recent past.The skin barrier is important for the control of the transe-
pidermal loss of water and provides protection of the
organism against the intrusion of external pathogens.
The role of barrier disruption for the development of atopic
diseases was made particularly obvious when mutations
were identified in FLG (MIM 135940), which can give
rise to ichthyosis vulgaris and lead to an increased
susceptibility to atopic dermatitis.1,2 Filaggrin, encoded
by FLG, is a key constituent of the epidermal barrier.
Mice with a mutation in Flg showed elevated IgE levels
because of a skin barrier defect after application of aller-
gens.3 Generalized peeling skin disease (PSD, MIM
270300) with pruritus and atopic diseases, also referred to
as peeling skin syndrome type B, is an unusual auto-
somal-recessive ichthyosiform erythroderma characterized
by lifelong patchy peeling of the entire skin with an onset
at birth or shortly thereafter.4,5 Several patients have been
reported who showed PSD with a strong association of
pruritus and high IgE levels.4,6–14
PSD shares several clinical features with Netherton
syndrome (NS, MIM 256500), such as frequent flares
of erythema and scaling and strong association with
atopic diseases.5,15 Moreover, both diseases appear very
similar at the histological and ultrastructural level,
showing an enhanced detachment of corneocytes.4,16
However, individuals with generalized PSD do not show
trichorrhexis invaginata (‘‘bamboo hairs’’), nor was it
possible to demonstrate SPINK5 (MIM 605010) mutations,
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peeling skin syndrome (MIM 609796), which is due to
autosomal-recessive mutations in the gene of transgluta-
minase 5 (TGM5, MIM 603805),17 and from peeling skin
syndrome type A, which is characterized by asymptomatic
and noninflammatory peeling and often starts at 3 to 6
years of age.5,18
We have studied a large consanguineous Roma family
from Germany with four individuals with generalized
superficial skin peeling since birth (Figure 1), severe
pruritus, and atopic manifestations with seasonal varia-
tion. The study was approved by the institutional review
board of the University Hospital of Mu¨nster, and all
patients enrolled gave their informed consent. A detailed
medical and dermatological history was obtained from all
affected persons. The clinical features are summarized in
Table 1. The initial clinical presentation was in the first
week of life in all four patients. The disease presented as
an unusual ichthyosiform erythroderma with white,
superficial exfoliation (Figure 1A), with normal birth
weight and growth, and without clinical signs for a syn-
dromic form of ichthyosis. However, an initial mild failure
to thrive and some periods of Staphylococcus aureus skin
infections were noted in the first few years of life. Most
strikingly, the affected individuals showed severe pruritus,
especially in warm weather, food allergies to nuts and fish,
and repeated episodes of angioedema, urticaria, and/or
asthma. Overall IgE levels were highly elevated (Table 1).
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Figure 1. Clinical Appearance of Peeling Skin
Disease and Pedigree of the Family Analyzed
(A) Shortly after birth, patient 1 developed an
unusual ichthyosiform skin condition with
erythema and superficial white scaling. Patient 3
reported seasonal variation of scaling and pruritus,
depending on the climate. All patients reported
mild to moderate nail changes.
(B) Histopathology (left) revealed an extensive
detachment of the stratum corneum (SC) directly
above the stratum granulosum (SG) (*). Ultrastruc-
ture (right) showed split formation between
keratinocytes of the SG and corneocytes of the SC,
as well as weak lateral adhesion of corneocytes.
Corneodesmosomes (arrows) are hardly visible; scale
bar represents 5 mm.and it could be plucked easily (P2 and P3). Patients did not
show any hair loss, and hair shaft analysis did not reveal
trichorrhexis invaginata, which would have been diag-
nostic for NS. Punch biopsies (4 mm) for histopathology
and immunofluorescence analysis were taken from all
patients. In addition, biopsies for ultrastructural analysis
and isolation of keratinocytes were taken from patient
3 (P3). Specimens for ultrastructural analysis were pro-
ceeded and examined as described previously.16 Similarly
to NS, histological and ultrastructural analyses of the skin
showed an enhanced detachment of corneocytes
(Figure 1B).4,16 However, we have not identified mutations
in the genes SPINK5 or TGM5.
We carried out a whole-genome linkage analysis via
chip-based SNP analysis. Peripheral blood was collected
in EDTA from all available family members, and DNA
was extracted from leukocytes via standard procedures.
DNA samples of three affected children and their parents,
representing one family branch each (see Figure S1 avail-
able online), were genotyped via the Affymetrix GeneChip
Human Mapping 250K Sty Array (Affymetrix). Genotypes
were called by the GeneChip DNA Analysis Software (Affy-
metrix). Data were checked using the program Graphical
Representation of Relationships.19 Parametric linkage
analysis was done with the programs Allegro20 and
MERLIN.21 All data handling was done via the graphical
user interface ALOHOMORA.22 Linkage analysis identified
a candidate region on chromosome 6p (Figure 2A). RefinedThe American Journal ofmapping localized the gene to a 3.3 cM
interval with a maximum LOD score of 5.4,
corresponding to 5.7 Mb in length, assuming
two separate pedigrees with two affected indi-
viduals each (Figure S1). Because an undefined
connection exists between both branches of
the family and because they originated from
the same tribe, we then searched for identical
homozygous intervals between all four
patients by using SNPs and microsatellites in
the linked region. The largest homozygous
interval was 3.0 Mb in length and contained
195 genes. CDSN (MIM 602593), located inthe minimal interval, was chosen as a functional candidate
gene because it encodes a component of the corneodesmo-
somes in the epidermal stratum corneum, and it was
analyzed for mutations. The coding region was sequenced
in the patients and in their parents and siblings
(NM_001264.3; Table S1). All four affected children
showed the same homozygous nonsense mutation in
CDSN, c.175A>T, resulting in a premature termination
codon, p.Lys59X (Figures 2B and 2C). We observed full co-
segregation of the mutation in the entire family (Figure S1)
and did not detect the mutation among 220 chromosomes
from ethnically matching control persons.
To investigate CDSN expression, we isolated total RNA
from primary keratinocytes cultured with 1.2 mM Ca2þ.
RNA was adjusted and quantified via one-step qRT-PCR
(Table S1) with SYBR GreenER labeling (Invitrogen) on
a LightCycler 480 system (Roche Applied Sciences).
Normalization was done with ACTB, RPS18, and 18S
RNA. Relative quantification showed a reduction of
CDSN mRNA amounts by 75%, pointing to nonsense-
mediated CDSN mRNA decay (Figure S2). Equal quantities
of protein isolated from primary keratinocytes were sepa-
rated by 10% SDS-PAGE under reducing conditions and
transferred to polyvinylidene fluoride membrane (Milli-
pore). The blots were probed with primary antibodies
directed against corneodesmosin, transglutaminase 1,
and actin. Immunoblot analysis demonstrated the absence
of corneodesmosin in the patient, whereas differentiatedHuman Genetics 87, 274–281, August 13, 2010 275
Table 1. Clinical Features of Patients P1–P4
Disease Phenotype
P1 P2 P3 P4
10 yrs (male) 8 yrs (female) 9 yrs (male) 1 yr (male)
Onset and initial clinical
presentation
Second day of life Second day of life Second day of life Second day of life
Superficial exfoliation
with unusual
ichthyosiform
erythroderma
Superficial exfoliation
with unusual
ichthyosiform
erythroderma
Superficial exfoliation
with unusual
ichthyosiform
erythroderma
Superficial exfoliation
with unusual
ichthyosiform
erythroderma
Disease course Erythematous patches
that start scaling after few
days, heal, and reoccur;
severe exacerbations
within the first 4 years of
life
Erythematous patches
that start scaling after few
days, heal and reoccur;
severe exacerbations
within the first 4 years of
life
Erythematous patches
that start scaling after few
days, heal and reoccur;
severe exacerbations
within the first 4 years of
life
Erythematous patches
that start scaling after
few days, heal and
reoccur; severe
exacerbations
Seasonal variation Not specifically Yes (severe scaling in
winter, severe pruritus in
summer)
Yes (severe pruritus in
summer)
Yes
Clinical Features
Scaling
Distribution Generalized Generalized Generalized Generalized
Type Exfoliative Exfoliative Exfoliative Exfoliative
Color White White White White
Palmoplantar features Episodically scaling,
hyperhidrosis
Mostly uninvolved Hyperhidrosis Mostly uninvolved
Hair abnormalities No trichorrhexis
invaginata, normal hair
growths, brittle hair in
early infancy
No trichorrhexis
invaginata, easy plugging
of the hair, normal hair
growths, brittle hair in
early infancy
No trichorrhexis
invaginata, easy plugging
of the hair, normal hair
growths
No trichorrhexis
invaginata, normal hair
growths
Nail abnormalities Mild onychodystrophy,
white nail changes
Recurrent onycholysis
since sixth year of life
Not specifically, white nail
changes
Not specifically, white
nail changes
S. aureus superinfection Frequent during the first 4
years of life
Frequent during the first 4
years of life
Frequent during the first 4
years of life
Present
Growths Normal birth weight and
size, mild failure to thrive
during the first ~4 years of
life
Normal birth weight and
size, mild failure to thrive
during the first ~4 years of
life
Normal birth weight and
size, mild failure to thrive
during the first ~4 years of
life
Normal
Height (present age) At 50th percentile At 50th percentile At 50th percentile At 50th percentile
Weight (present age) At 10th percentile At 10th percentile At 10th percentile At 10th percentile
Atopic Features
Pruritus Moderate to severe Moderate to severe Moderate to severe Moderate
Total IgE level 2076 IU/ml (<100)a ND >2000 IU/ml (<100)a ND
Eosinophils 0.7 3 103/ml (<0.44)a ND 0.79 3 103/ml (<0.60)a ND
Food intolerances Nuts, fish Fish Nuts, fish Unknown
Others – History of urticaria with
angioedema
History of asthma when
in contact with fish
–
ND, not determined.
a Normal values.keratinocytes of healthy controls showed a strong signal
(Figure 2D). Transglutaminase 1 was detected as a late
differentiation control in differentiated keratinocytes
from both patients and unaffected persons.
Immunohistochemistry on skin biopsy samples was
performed with antibodies against involucrin, filaggrin,276 The American Journal of Human Genetics 87, 274–281, August 1loricrin, and keratins 2, 10, and 14. Direct immunofluores-
cenceanalysis was performed on cryosections for corneo-
desmosin, desmocollin 1, transglutaminase 1, LEKTI,
desmoglein 1, transglutaminase 5, and elafin. Antigen
mapping of corneodesmosin was negative for all skin
biopsies of the patients (Figure 3A). In contrast, other3, 2010
Figure 2. Mapping of the Gene and
Identification of the Underlying Genetic
Defect
(A) Multipoint linkage analysis revealed
a locus on chromosome 6p. For reasons
of clarity, LOD scores below –3 are not
shown. Vertical lines denote boundaries
of the chromosomes, which are labeled
above the graph.
(B) The mutation was found in exon 2 of
CDSN. The position within the proposed
protein structure is shown.
(C) Sequencing analysis of CDSN showed
a homozygous transversion (indicated by
an arrow) at c.175 in all affected individ-
uals, resulting in a termination codon.
(D) Protein extracts from normal keratino-
cytes and keratinocytes of patient 3 were
subjected to immunoblot analysis. Poly-
peptides of ~54 kDa and 45 kDa cor-
respond to full-length and proteolytically
processed forms of corneodesmosin.
Preparations from differentiated patient
keratinocytes (þCa2þ) did not show any
corneodesmosin signal. Transglutaminase
1 (TGase1) served as a late differentiation
control.components of the desmosomes and corneodesmosomes,
i.e., desmocollin 1 and desmoglein 1, showed an almost
regular expression. LEKTI, missing in NS, presented
a broadened signal zone in the upper epidermal layers of
our patients, transglutaminase 5 was normal, and further
late epidermal differentiation markers, e.g., filaggrin, invo-
lucrin, loricrin, transglutaminase 1, and keratin 2, likewise
showed an enhanced immunohistochemical staining
(Figure 3B; Figure S3). These proteins are important for
the cornified cell envelope formation, and the changes
probably reflect homeostatic responses to epidermal stress
or inflammation.
To further study the lack of corneodesmosin in PSD that
is supposed to lead to an increased desquamation of the
corneocytes, we generated three-dimensional skin models
by using organotypic tissue coculture systems. Primary
human keratinocytes (NHEKs) were isolated from foreskin
obtained after juvenile circumcision in an age-matched,
9-year-old boy and from patient skin biopsy samples (P3)
and were cultivated until second passage in the presence
of a feeder layer of irritated 3T3 mouse fibroblasts, as
described.23 Tissue engineering was performed as reported
elsewhere in more detail (K.-M.E. and H.C.H. et al., unpub-
lished data). In brief, NHEKs were isolated from foreskinThe American Journal of Human Gobtained after juvenile circumcision
in an age-matched boy and from
patient skin punch biopsy samples
(P3) and cultivated in the presence
of a feeder layer of irritated 3T3mouse
fibroblasts.23 Passage 2 keratinocytes
were cultivated in serum-free, defined
cultivation media without feeder cellswith 0.15 mM Ca2þ. Normal human dermal fibroblasts
(NHDF) were isolated from neonatal foreskin and patient
skin biopsy samples and were cultivated in DMEM with
10% fetal calf serum (FCS), 100 IU/ml penicillin, and
100 mg/ml streptomycin. Six-well plates with 3 mm inserts
with 4.22 cm2 growth area (BD Biosciences) were used.
For each well, a mixture of collagen I (bovine, Nutacon)
and 103 HBSS was brought to neutral pH with NaOH,
2.5 3 105 NHDF in FCS was added, and the mixture was
poured into the filter insert. The matrix was stored for
2–4 hr in a CO2-free incubator before keratinocyte growth
mediumwas added. The system was transferred to an incu-
bator with 5% CO2 and 95% humidity. After removing the
medium from the top, 4.5 3 106 to 5.2 3 106 NHEK was
seeded onto the matrices. On the next day, the medium
was changed to defined cultivation medium.24 Models
were cultivated for 8 days and then harvested with biopsy
punches (5 to 8 mm). Either samples were processed and
embedded in paraffin or RNA and protein were isolated.
Skin equivalents with patient fibroblasts and keratino-
cytes (Figure 4A) demonstrated formation of the basal ker-
atinocyte layer and the dermal-epidermal junction zone
and terminal keratinocyte differentiation in the epidermis
models, as shown by hematoxylin and eosin (H & E)enetics 87, 274–281, August 13, 2010 277
Figure 3. Characterization of Patient Epidermis
(A) Immunofluorescence study revealed a pericellular
corneodesmosin signal within the upper SG and
lower SC. In contrast, epidermis of patients 1 and
3 showed no signal. Scale bars represent 20 mm.
(Ba–Bf) LEKTI, deficient in Netherton syndrome,
showed a broad and strong expression in the skin
of the PSD patients (Ba and Bd). Further desmosomal
components, i.e., desmocollin 1 (Dsc1, Bb and Be)
and desmoglein 1 (Dsg1, Bc and Bf), showed a strong
presence in the skin of the patients (only P3 is
shown). Scale bars represent 20 mm.staining (Figure 4A) and immunofluorescence staining of
markers such as integrin b1, collagen IV, keratin 14, and
keratin 10 (data not shown). Less well-organized epidermal
structure and extended expression of late differentiation
markers such as involucrin and filaggrin (Figure 4B)
compared to skin equivalents with normal keratinocytes
resembled our findings in patient skin. Consistent with
the findings in patient skin biopsy specimens, we showed
a complete loss of corneodesmosin (Figure 4B). We further-
more analyzed the presence of secreted serine proteases of
the epidermis. Staining of kallikrein 5 was elevated in
patient models and the expression was broadened in the
epidermis, consistent with the results from a recent study.9
These results pointed to a disturbance of terminal
epidermal differentiation upon loss of corneodesmosin
and a deregulation of proteins playing a role for the corni-
fied cell envelope and corneodesmosome degradation.
The generation of three-dimensional models precisely
replicating the epidermal skin enabled us to further
analyze the epidermal barrier integrity. Test substances
were the Organisation for Economic Cooperation and
Development-proposed standard compounds for cuta-
neous absorption studies, caffeine and testosterone
(Sigma-Aldrich). Experiments were performed according
to a validated protocol,25 which was proved to be appli-
cable to the use of reconstructed full-thickness skin.26
Briefly, stock solutions of testosterone (40 mg/ml) and278 The American Journal of Human Genetics 87, 274–281, August 13, 2010caffeine (1000 mg/ml) were spiked with an
appropriate amount of the radiolabeled agent
to achieve a total radioactivity of 2 mCi/ml.
Special inserts constructed for the EPISKIN
model27 were used with an assayed surface
area of 0.357 cm2. Skin models were mounted
into Franz cells (diameter 15 mm, volume
12 ml; PermeGear) with the stratum corneum
facing the air. The system was allowed to
equilibrate for 30 min before a sample of
receptor fluid was collected. Subsequently,
110 ml of spiked caffeine and testosterone solu-
tions was applied on the reconstructed skin
model, resulting in a dose of 284.1 mg/cm2 of
caffeine and a dose of 11.36 mg/cm2 of testos-
terone, respectively. Receptor fluid was
sampled repeatedly every half hour andreplaced by fresh PBS. Permeation tests were performed
at least in quadruplicates except for the first experiment
with patient cells, which was performed in duplicate.
Two independent experiments were performed with
control cells and patient cells. For each experiment, cumu-
lative amounts of the permeated compounds in the
receptor medium were plotted versus time (mean
values5 standard deviation [SD]).
The apparent permeability coefficient Papp and lag time
were calculated from a regression line based on mean
values of the experiment.28 Normal skin models showed
significantly lower permeation values (Figure 4C), though
they slightly exceeded those obtained with a commercially
available reconstructed skin model.26 The Papp values with
testosterone were 8.58 3 106 5 1.47 3 106 cm/s and
5.29 3 106 5 0.72 3 106 cm/s, respectively, in patient
models compared to models with normal keratinocytes
(mean values 5 SD; p ¼ 0.0039) and 13.79 3 106 5
1.84 3 106 cm/s and 10.78 3 106 5 0.82 3 106 cm/s,
respectively, with caffeine (p ¼ 0.017). Thus, we identified
a severe barrier defect in patient models with the lack of
corneodesmosin.
Corneodesmosin is a phosphorylated basic keratinocyte
adhesion glycoprotein located in the extracellular part of
the desmosomes and corneodesmosomes at the transition
from the stratum granulosum (SG) to the stratum corneum
(SC) and in the inner root sheath of the hair follicles.29
Figure 4. Three-Dimensional Epidermis Models and Analysis
of the Barrier Defect
(A) H & E staining of reconstructed epidermis with keratinocytes
from healthy probands demonstrated an even structure of the
epidermis. Models with keratinocytes from patient 3 (P3) showed
a loose and increased stratum corneum and a more irregular orga-
nization of differentiating keratinocytes.
(B) Immunofluorescence analysis confirmed the lack of corneodes-
mosin in models generated from patient keratinocytes, in contrast
to normal epidermis equivalents. Normal epidermis equivalents
showed regular terminal differentiation with a synthesis of kalli-
krein 5 and filaggrin. The expression patterns of KLK5 and FLG
appeared strong and broadened in patient models.
(C) Models with normal keratinocytes exhibited a barrier function
comparable to standardized skin models. Clearly increased testos-
terone permeation into models with patient keratinocytes
demonstrated a severe epidermal barrier defect (mean values 5
SD for each time point).
The AmericThe 52–56 kDa precursor form is synthesized in the middle
epidermis, transported via lamellar bodies, and secreted
into the extracellular space, where it associates to the
desmosome core and the cornified cell envelope. Two
glycine- and serine-rich domains, from amino acids
65–175 and 375–450, are responsible for forming adhesive
secondary structures similar to glycine loops. Functionally,
corneodesmosin reinforces cell-cell cohesion within the
upper epidermis and the stratum corneum. Kallikrein
5 (stratum corneum tryptic enzyme) and kallikrein
7 (stratum corneum chymotryptic enzyme) cooperate to
progressively proteolyse corneodesmosin. Its degradation
is necessary for desquamation.30,31
An uncommon human hair disease was described earlier
that was caused by autosomal-dominant mutations in
CDSN: heterozygous nonsense mutations, namely
p.Gln200X, p.Gln215X, and p.Tyr239X, were shown in
a specific type of hypotrichosis simplex (MIM
146520).32,33 Affected individuals have normal hair in
early childhood but experience progressive loss of scalp
hair beginning in the middle of the first decade of life
and almost complete baldness by the third decade; they
do not show any signs of skin disease. It was assumed
that abnormal corneodesmosin aggregates could exert
a toxic effect to the hair follicle cells, thereby contributing
to permanent hair loss.32 Of note, the phenotype of hypo-
trichosis simplex does not include skin peeling or ichthyo-
sis, which could be explained by the presence of a normal
allele in these patients. In our families, heterozygous
carriers of the recessive mutation p.Lys59X did not show
any skin or hair phenotype. Hence, hypotrichosis simplex
and PSD can be assumed to involve different pathome-
chanisms.
Review of the literature,4,6,10,13 dermatological question-
ing, and clinical examination revealed that PSD is associ-
ated with a clinically asymptomatic hair phenotype,
namely a mild hair-anchoring deficiency. A recent mouse
model with targeted deletion of the murine corneodesmo-
sin gene underlined the essential role of the protein for the
hair physiology.34 In mice, Cdsn-deficient skin showed
rapid hair loss. The strong expression of CDSN in the inner
root sheath of human hair follicles, including the inner-
most cuticle layer,34 points to an important role of corneo-
desmosin for the hair-anchoring structure. The rather mild
hair phenotype in PSD patients in contrast to mice with
Cdsn-deficient skin, however, might reflect the differences
in structure and size of mouse skin and mouse hair growth
pattern.
Inactivation of corneodesmosin in mouse skin resulted
in early postnatal death because of a breakdown of the
epidermal barrier shortly after birth, when mechanical
stress of a normal postnatal environment was exerted
onto the skin.34,35 The defect of the epidermal barrier
was accompanied by a 10-fold increase in transepidermal
water loss.35 Here we have shown the impaired epidermal
barrier caused by corneodesmosin deficiency in humans,
which is evident clinically, e.g., by failure to thrive in earlyan Journal of Human Genetics 87, 274–281, August 13, 2010 279
infancy,36 by ultrastructure analysis, which showed an
extremely reduced coherence of corneocytes (Figure 1B),
and by increased permeability of reagents into the
epidermis (Figure 4C). The less-developed barrier is well
in accordance with the sensitivity for irritants in patients
with atopic diseases. We assume that the compromised
epidermal barrier of corneodesmosin-deficient skin may
facilitate the increased penetration of allergens into the
epidermis, which could explain the development of atopic
manifestations. A similar example is filaggrin deficiency,
which can give rise to ichthyosis vulgaris and lead to an
increased susceptibility to atopic dermatitis.2,3,37–39 Inter-
estingly, our patients also showed manifest food allergies,
i.e., to fish and nuts.
We conclude that a nonsense mutation in CDSN, which
leads to the complete loss of corneodesmosin, causes
peeling skin disease. Corneodesmosin is vastly important
for the epidermal barrier integrity, and its absence may
give rise to a strong predisposition to atopic manifesta-
tions. Corneodesmosin deficiency may therefore function
as a novel humanmodel disorder for atopic diseases, as did
Netherton syndrome and ichthyosis vulgaris in the recent
past.Supplemental Data
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